Sign up to save your podcastsEmail addressPasswordRegisterOrContinue with GoogleAlready have an account? Log in here.
November 28, 2012Tofacitinib Approved: Now How Do We Use It?PlayDr. Jonathan Kay discusses the potential role of the recently approved oral kinase inhibitor tofacitinib for rheumatoid arthritis....moreShareView all episodesBy MedscapeNovember 28, 2012Tofacitinib Approved: Now How Do We Use It?PlayDr. Jonathan Kay discusses the potential role of the recently approved oral kinase inhibitor tofacitinib for rheumatoid arthritis....more
Dr. Jonathan Kay discusses the potential role of the recently approved oral kinase inhibitor tofacitinib for rheumatoid arthritis.
November 28, 2012Tofacitinib Approved: Now How Do We Use It?PlayDr. Jonathan Kay discusses the potential role of the recently approved oral kinase inhibitor tofacitinib for rheumatoid arthritis....more
Dr. Jonathan Kay discusses the potential role of the recently approved oral kinase inhibitor tofacitinib for rheumatoid arthritis.